Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation

Genes, Brain and Behavior

Volumn 14, Issue 1, 2015, Pages 98-135

  Phillips, T J ^a,b   Reed, C ^b   Pastor, R ^b,c,d  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITAT JAUME I   (Spain)

^d REED COLLEGE   (United States)

Author keywords

Alcohol; Alcohol use disorder; Ethanol drinking; Ethanol seeking; Genetic animal model; HPA axis; Knockout; Pharmacology; Pharmacotherapy; Sensitization; Stress; Urocortin

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; 4 (2 CHLORO 4 METHOXY 5 METHYLPHENYL) N [2 CYCLOPROPYL 1 (3 FLUORO 4 METHYLPHENYL)ETHYL] 5 METHYL N (2 PROPYNYL) 2 THIAZOLAMINE; 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; ANTALARMIN; ANTISAUVAGINE 30; BINDING PROTEIN; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; HORMONE RECEPTOR AFFECTING AGENT; LIGAND; METYRAPONE; MIFEPRISTONE; NEUROTRANSMITTER; SPIRONOLACTONE; UNCLASSIFIED DRUG; UROCORTIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ADAPTATION; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; DRINKING BEHAVIOR; DRUG DEPENDENCE; GABAERGIC TRANSMISSION; GENE FUNCTION; GENE MUTATION; HORMONE RECEPTOR INTERACTION; HUMAN; IMMOBILIZATION STRESS; MENTAL DISEASE; MOTIVATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM FUNCTION; NEUROTRANSMISSION; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REINFORCEMENT; REVIEW; REWARD; RODENT; SENSITIZATION; SIGNAL TRANSDUCTION; STRESS; TRANSGENIC MOUSE; ANIMAL; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALIA; PRIMATES; RODENTIA;

ADAPTATION, PHYSIOLOGICAL; ALCOHOL DRINKING; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; HUMANS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION;

EID: 84922668952     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12189     Document Type: Review

References (287)

1. Adler, C.M., Elman, I., Weisenfeld, N., Kestler, L., Pickar, D. & Breier, A. (2000) Effects of acute metabolic stress on striatal dopamine release in healthy volunteers. Neuropsychopharmacology 22, 545-550.
2. Aguilar, M.A., Garcia-Pardo, M.P., Montagud-Romero, S., Minarro, J. & Do Couto, B.R. (2013) Impact of social stress in addiction to psychostimulants: what we know from animal models. Curr Pharm Des 19, 7009-7025.
3. Ahima, R., Krozowski, Z. & Harland, R. (1991) Type I corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J Comp Neurol 313, 522-538.
4. Alderman, S.L. & Bernier, N.J. (2007) Localization of corticotropin-releasing factor, urotensin I, and CRF-binding protein gene expression in the brain of the zebrafish, Danio rerio. J Comp Neurol 502, 783-793.
5. Allen, C.D., Rivier, C.L. & Lee, S.Y. (2011) Adolescent alcohol exposure alters the central brain circuits known to regulate the stress response. Neuroscience 182, 162-168.
6. Armario, A. (2006) The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors? CNS Neurol Disord Drug Targets 5, 485-501.
7. Armario, A. (2010) Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci 31, 318-325.
8. Aubry, J.M. (2013) CRF system and mood disorders. J Chem Neuroanat 54, 20-24.
9. Ayanwuyi, L.O., Carvajal, F., Lerma-Cabrera, J.M., Domi, E., Bjork, K., Ubaldi, M., Heilig, M., Roberto, M., Ciccocioppo, R. & Cippitelli, A. (2013) Role of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of Marchigian Sardinian alcohol-preferring rats. Front Psychiatry 4, 23. doi: 10.3389/fpsyt.2013.00023.
10. Bajo, M., Cruz, M.T., Siggins, G.R., Messing, R. & Roberto, M. (2008) Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proc Natl Acad Sci U S A 105, 8410-8415.
11. Baldwin, H.A., Rassnick, S., Rivier, J., Koob, G.F. & Britton, K.T. (1991) CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) 103, 227-232.
12. Bale, T.L. & Chen, A. (2012) Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit. Endocrinology 153, 2556-2561.
13. Bale, T.L. & Vale, W.W. (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44, 525-557.
14. Barr, C.S., Dvoskin, R.L., Yuan, Q., Lipsky, R.H., Gupte, M., Hu, X., Zhou, Z., Schwandt, M.L., Lindell, S.G., McKee, M., Becker, M.L., Kling, M.A., Gold, P.W., Higley, D., Heilig, M., Suomi, S.J. & Goldman, D. (2008) CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques. Arch Gen Psychiatry 65, 934-944.
15. Barr, C.S., Dvoskin, R.L., Gupte, M., Sommer, W., Sun, H., Schwandt, M.L., Lindell, S.G., Kasckow, J.W., Suomi, S.J., Goldman, D., Higley, J.D. & Heilig, M. (2009) Functional CRH variation increases stress-induced alcohol consumption in primates. Proc Natl Acad Sci U S A 106, 14593-14598.
16. Bell, S.M., Reynolds, J.G., Thiele, T.E., Gan, J., Figlewicz, D.P. & Woods, S.C. (1998) Effects of third intracerebroventricular injections of corticotropin-releasing factor (CRF) on ethanol drinking and food intake. Psychopharmacology (Berl) 139, 128-135.
17. Berridge, K.C. & Kringelbach, M.L. (2013) Neuroscience of affect: brain mechanisms of pleasure and displeasure. Curr Opin Neurobiol 23, 294-303.
18. Bittencourt, J.C. & Sawchenko, P.E. (2000) Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J Neurosci 20, 1142-1156.
19. Bittencourt, J.C., Vaughan, J., Arias, C., Rissman, R.A., Vale, W.W. & Sawchenko, P.E. (1999) Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 415, 285-312.
20. Boden, J.M. & Fergusson, D.M. (2011) Alcohol and depression. Addiction 106, 906-914.
21. Bonfiglio, J.J., Inda, C., Refojo, D., Holsboer, F., Arzt, E. & Silberstein, S. (2011) The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: molecular and cellular mechanisms involved. Neuroendocrinology 94, 12-20.
22. Breese, G.R., Knapp, D.J. & Overstreet, D.H. (2004) Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist. Neuropsychopharmacology 29, 470-482.
23. Breese, G.R., Overstreet, D.H. & Knapp, D.J. (2005a) Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis. Psychopharmacology (Berl) 178, 367-380.
24. Breese, G.R., Overstreet, D.H., Knapp, D.J. & Navarro, M. (2005b) Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology 30, 1662-1669.
25. Broadbear, J.H., Winger, G., Rice, K.C. & Woods, J.H. (2002) Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys. Psychopharmacology (Berl) 164, 268-276.
26. Brown, M. (1986) Corticotropin releasing factor: central nervous system sites of action. Brain Res 399, 10-14.
27. Bruijnzeel, A.W., Small, E., Pasek, T.M. & Yamada, H. (2010) Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats. Behav Brain Res 210, 288-291.
28. Burattini, C., Gill, T.M., Aicardi, G. & Janak, P.H. (2006) The ethanol self-administration context as a reinstatement cue: acute effects of naltrexone. Neuroscience 139, 877-887.
29. Burke, A.R. & Miczek, K.A. (2014) Stress in adolescence and drugs of abuse in rodent models: role of dopamine, CRF, and HPA axis. Psychopharmacology (Berl) 231, 1557-1580.
30. Cador, M., Cole, B.J., Koob, G.F., Stinus, L. & Le Moal, M. (1993) Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine. Brain Res 606, 181-186.
31. Cavalcante, J.C., Sita, L.V., Mascaro, M.B., Bittencourt, J.C. & Elias, C.F. (2006) Distribution of urocortin 3 neurons innervating the ventral premammillary nucleus in the rat brain. Brain Res 1089, 116-125.
32. Chen, A.C., Manz, N., Tang, Y., Rangaswamy, M., Almasy, L., Kuperman, S., Nurnberger, J. Jr., O'Connor, S.J., Edenberg, H.J., Schuckit, M.A., Tischfield, J., Foroud, T., Bierut, L.J., Rohrbaugh, J., Rice, J.P., Goate, A., Hesselbrock, V. & Porjesz, B. (2010) Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence. Alcohol Clin Exp Res 34, 988-996.
33. Chu, K., Koob, G.F., Cole, M., Zorrilla, E.P. & Roberts, A.J. (2007) Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol Biochem Behav 86, 813-821.
34. Ciccocioppo, R., Gehlert, D.R., Ryabinin, A. et al. (2009) Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond. Alcohol 43, 491-498.
35. Cippitelli, A., Damadzic, R., Singley, E., Thorsell, A., Ciccocioppo, R., Eskay, R.L. & Heilig, M. (2012) Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav 100, 522-529.
36. Cippitelli, A., Ayanwuyi, L.O., Barbier, E., Domi, E., Lerma-Cabrera, J.M., Carvajal, F., Scuppa, G., Li, H., Ubaldi, M., Heilig, M., Roberto, M. & Ciccocioppo, R. (2014) Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats. Psychopharmacology (Berl) doi: 10.1007/s00213-014-3743-7 [Epub ahead of print].
37. Clapp, P., Bhave, S.V. & Hoffman, P.L. (2008) How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health 31, 310-339.
38. Cole, B.J., Cador, M., Stinus, L., Rivier, J., Vale, W., Koob, G.F. & Le Moal, M. (1990) Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res 512, 343-346.
39. Coste, S.C., Kesterson, R.A., Heldwein, K.A., Stevens, S.L., Heard, A.D., Hollis, J.H., Murray, S.E., Hill, J.K., Pantely, G.A., Hohimer, A.R., Hatton, D.C., Phillips, T.J., Finn, D.A., Low, M.J., Rittenberg, M.B., Stenzel, P. & Stenzel-Poore, M.P. (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24, 403-409.
40. Coste, S.C., Heard, A.D., Phillips, T.J. & Stenzel-Poore, M.P. (2006) Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress. Genes Brain Behav 5, 131-138.
41. Cowen, M.S., Chen, F. & Lawrence, A.J. (2004) Neuropeptides: implications for alcoholism. J Neurochem 89, 273-285.
42. Crabbe, J.C., Phillips, T.J., Harris, R.A., Arends, M.A. & Koob, G.F. (2006) Alcohol-related genes: contributions from studies with genetically engineered mice. Addict Biol 11, 195-269.
43. Criado, J.R., Liu, T., Ehlers, C.L. & Mathe, A.A. (2011) Prolonged chronic ethanol exposure alters neuropeptide Y and corticotropin-releasing factor levels in the brain of adult Wistar rats. Pharmacol Biochem Behav 99, 104-111.
44. Dave, J.R., Eiden, L.E., Karanian, J.W. & Eskay, R.L. (1986) Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat. Endocrinology 118, 280-286.
45. De Souza, E.B. (1995) Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20, 789-819.
46. Deussing, J.M., Breu, J., Kühne, C., Kallnik, M., Bunck, M., Glasl, L., Yen, Y.C., Schmidt, M.V., Zurmuhlen, R., Vogl, A.M., Gailus-Durner, V., Fuchs, H., Holter, S.M., Wotjak, C.T., Landgraf, R., de Angelis, M.H., Holsboer, F. & Wurst, W. (2010) Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J Neurosci 30, 9103-9116.
47. Dhaher, R., Finn, D., Snelling, C. & Hitzemann, R. (2008) Lesions of the extended amygdala in C57BL/6J mice do not block the intermittent ethanol vapor-induced increase in ethanol consumption. Alcohol Clin Exp Res 32, 197-208.
48. Duvarci, S. & Pare, D. (2014) Amygdala microcircuits controlling learned fear. Neuron 82, 966-980.
49. Egli, M. (2005) Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? Addict Biol 10, 309-319.
50. Ehlers, C.L., Chaplin, R.I., Wall, T.L., Lumeng, L., Li, T.K., Owens, M.J. & Nemeroff, C.B. (1992) Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats. Psychopharmacology (Berl) 106, 359-364.
51. Enoch, M.A., Shen, P.H., Ducci, F., Yuan, Q., Liu, J., White, K.V., Albaugh, B., Hodgkinson, C.A. & Goldman, D. (2008) Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP. PLoS One 3, e3620. doi: 10.1371/journal.pone.0003620.
52. Errico, A.L., Parsons, O.A., King, A.C. & Lovallo, W.R. (1993) Attenuated cortisol response to biobehavioral stressors in sober alcoholics. Alcohol 54, 393-398.
53. Fahlke, C., Hard, E. & Hansen, S. (1996) Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone. Psychopharmacology (Berl) 127, 133-139.
54. Falco, A.M., Bergstrom, H.C., Bachus, S.E. & Smith, R.F. (2009) Persisting changes in basolateral amygdala mRNAs after chronic ethanol consumption. Physiol Behav 96, 169-173.
55. Fee, J.R., Sparta, D.R., Picker, M.J. & Thiele, T.E. (2007) Corticotropin releasing factor-1 receptor antagonist, CP-154, 526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J mice. Neuroscience 150, 14-21.
56. File, S.E. (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 2, 219-238.
57. Finn, D.A., Snelling, C., Fretwell, A.M., Tanchuck, M.A., Underwood, L., Cole, M., Crabbe, J.C. & Roberts, A.J. (2007) Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41). Alcohol Clin Exp Res 31, 939-949.
58. Fonareva, I., Spangler, E., Cannella, N., Sabino, V., Cottone, P., Ciccocioppo, R., Zorrilla, E.P. & Ryabinin, A.E. (2009) Increased perioculomotor urocortin 1 immunoreactivity in genetically selected alcohol preferring rats. Alcohol Clin Exp Res 33, 1956-1965.
59. Funk, C.K. & Koob, G.F. (2007) A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res 1155, 172-178.
60. Funk, C.K., O'Dell, L.E., Crawford, E.F. & Koob, G.F. (2006) Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 26, 11324-11332.
61. Funk, C.K., Zorrilla, E.P., Lee, M.J., Rice, K.C. & Koob, G.F. (2007) Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 61, 78-86.
62. Gabriel, K.I., Yu, C.L., Osborn, J.A. & Weinberg, J. (2006) Prenatal ethanol exposure alters sensitivity to the effects of corticotropin-releasing factor (CRF) on behavior in the elevated plus-maze. Psychoneuroendocrinology 31, 1046-1056.
63. Gehlert, D.R., Cippitelli, A., Thorsell, A., Le, A.D., Hipskind, P.A., Hamdouchi, C., Lu, J., Hembre, E.J., Cramer, J., Song, M., McKinzie, D., Morin, M., Ciccocioppo, R. & Heilig, M. (2007) 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2, 6-dimethyl-imidazo [1, 2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27, 2718-2726.
64. George, O. & Koob, G.F. (2010) Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev 35, 232-247.
65. George, S.R., Fan, T., Roldan, L. & Naranjo, C.A. (1990) Corticotropin-releasing factor is altered in brains of animals with high preference for ethanol. Alcohol Clin Exp Res 14, 425-429.
66. Gerra, G., Somaini, L., Manfredini, M., Raggi, M.A., Saracino, M.A., Amore, M., Leonardi, C., Cortese, E. & Donnini, C. (2014) Dysregulated responses to emotions among abstinent heroin users: correlation with childhood neglect and addiction severity. Prog Neuropsychopharmacol Biol Psychiatry 48, 220-228.
67. Giardino, W.J. & Ryabinin, A.E. (2013) CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption. Alcohol Clin Exp Res 37, 1161-1170.
68. Giardino, W.J., Cocking, D.L., Kaur, S., Cunningham, C.L. & Ryabinin, A.E. (2011) Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference. PLoS One 6, e26997. doi: 10.1371/journal.pone.0026997.
69. Gilpin, N.W. (2012) Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors. Alcohol 46, 329-337.
70. Gilpin, N.W. (2014) Brain reward and stress systems in addiction. Front Psychiatry 5, 79.
71. Gilpin, N.W., Richardson, H.N. & Koob, G.F. (2008) Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res 32, 1535-1542.
72. Gilpin, N.W., Karanikas, C.A. & Richardson, H.N. (2012) Adolescent binge drinking leads to changes in alcohol drinking, anxiety, and amygdalar corticotropin releasing factor cells in adulthood in male rats. PLoS One 7, e31466. doi: 10.1371/journal.pone.0031466.
73. Gray, T.S. & Magnuson, D.J. (1992) Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13, 451-460.
74. Griffin, W.C. III (2014) Alcohol dependence and free-choice drinking in mice. Alcohol 48, 287-293.
75. Haass-Koffler, C.L. & Bartlett, S.E. (2012) Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity. Front Mol Neurosci 5, 91. doi: 10.3389/fnmol.2012.00091.
76. Haass-Koffler, C.L., Leggio, L. & Kenna, G.A. (2014) Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs 28, 343-360.
77. Handa, R.J. & Weiser, M.J. (2014) Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis. Front Neuroendocrinol 35, 197-220.
78. Hansson, A.C., Cippitelli, A., Sommer, W.H., Fedeli, A., Bjork, K., Soverchia, L., Terasmaa, A., Massi, M., Heilig, M. & Ciccocioppo, R. (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A 103, 15236-15241.
79. Hansson, A.C., Cippitelli, A., Sommer, W.H., Ciccocioppo, R. & Heilig, M. (2007) Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol. Addict Biol 12, 30-34.
80. Hauger, R.L., Risbrough, V., Brauns, O. & Dautzenberg, F.M. (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5, 453-479.
81. Hayes, D.M., Knapp, D.J., Breese, G.R. & Thiele, T.E. (2005) Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains. Alcohol Clin Exp Res 29, 721-729.
82. Heilig, M. & Egli, M. (2006) Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 111, 855-876.
83. Heilig, M. & Koob, G.F. (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30, 399-406.
84. Heilig, M., Thorsell, A., Sommer, W.H., Hansson, A.C., Ramchandani, V.A., George, D.T., Hommer, D. & Barr, C.S. (2010) Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev 35, 334-344.
85. Herman, J.P., Figueiredo, H., Mueller, N.K., Ulrich-Lai, Y., Ostrander, M.M., Choi, D.C. & Cullinan, W.E. (2003) Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24, 151-180.
86. Hodge, C.W., Mehmert, K.K., Kelley, S.P., McMahon, T., Haywood, A., Olive, M.F., Wang, D., Sanchez-Perez, A.M. & Messing, R.O. (1999) Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKC epsilon. Nat Neurosci 2, 997-1002.
87. Hodge, C.W., Raber, J., McMahon, T., Walter, H., Sanchez-Perez, A.M., Olive, M.F., Mehmert, K., Morrow, A.L. & Messing, R.O. (2002) Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase C epsilon. J Clin Invest 110, 1003-1010.
88. Hogan, J.B., Hodges, D.B., Jr., Lelas, S., Gilligan, P.J., McElroy, J.F. & Lindner, M.D. (2005) Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests. Psychopharmacology (Berl) 178, 410-419.
89. Hostetler, C.M. & Ryabinin, A.E. (2013) The CRF system and social behavior: a review. Front Neurosci 7, 92. doi: 10.3389/fnins.2013.00092.
90. Huang, M.M., Overstreet, D.H., Knapp, D.J., Angel, R., Wills, T.A., Navarro, M., Rivier, J., Vale, W. & Breese, G.R. (2010) Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. J Pharmacol Exp Ther 332, 298-307.
91. Huising, M.O., Vaughan, J.M., Shah, S.H., Grillot, K.L., Donaldson, C.J., Rivier, J., Flik, G. & Vale, W.W. (2008) Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not urocortin 1. J Biol Chem 283, 8902-8912.
92. Hwa, L.S., Debold, J.F. & Miczek, K.A. (2013) Alcohol in excess: CRF(1) receptors in the rat and mouse VTA and DRN. Psychopharmacology (Berl) 225, 313-327.
93. Hwa, L.S., Shimamoto, A., Kayyali, T., Norman, K.J., Valentino, R.J., DeBold, J.F. & Miczek, K.A. (2014) Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice. Addict Biol doi: 10.1111/adb.12189. [Epub ahead of print].
94. Hwang, B.H., Stewart, R., Zhang, J.K., Lumeng, L. & Li, T.K. (2004) Corticotropin-releasing factor gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a comparison between rat lines selectively bred for high and low alcohol preference. Brain Res 1026, 143-150.
95. Janssen, D. & Kozicz, T. (2013) Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health. Front Endocrinol (Lausanne) 4, 28. doi: 10.3389/fendo.2013.00028.
96. Jee, C., Lee, J., Lim, J.P., Parry, D., Messing, R.O. & McIntire, S.L. (2013) SEB-3, a CRF receptor-like GPCR, regulates locomotor activity states, stress responses and ethanol tolerance in Caenorhabditis elegans. Genes Brain Behav 12, 250-262.
97. Jenkins, J.S. & Connolly, J. (1968) Adrenocortical response to ethanol in man. Br Med J 2, 804-805.
98. Ji, D., Gilpin, N.W., Richardson, H.N., Rivier, C.L. & Koob, G.F. (2008) Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav Pharmcol 19, 1-12.
99. Justice, N.J., Yuan, Z.F., Sawchenko, P.E. & Vale, W. (2008) Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. J Comp Neurol 511, 479-496.
100. Kaur, S., Li, J., Stenzel-Poore, M.P. & Ryabinin, A.E. (2012) Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice. Alcohol Clin Exp Res 36, 369-376.
101. Kirkman, S. & Nelson, D.H. (1988) Alcohol-induced pseudo-Cushing's disease: a study of prevalence with review of the literature. Metabolism 37, 390-394.
102. de Kloet, E.R. (2013) Lifetime achievement from a brain-adrenal perspective: on the CRF-urocortin-glucocorticoid balance. J Chem Neuroanat 54, 42-49.
103. Knapp, D.J., Overstreet, D.H., Moy, S.S. & Breese, G.R. (2004) SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 32, 101-111.
104. Knapp, D.J., Overstreet, D.H., Huang, M., Wills, T.A., Whitman, B.A., Angel, R.A., Sinnett, S.E. & Breese, G.R. (2011a) Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. Psychopharmacology (Berl) 218, 179-189.
105. Knapp, D.J., Whitman, B.A., Wills, T.A., Angel, R.A., Overstreet, D.H., Criswell, H.E., Ming, Z. & Breese, G.R. (2011b) Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain Behav Immun 25(Suppl. 1), S146-S154.
106. Koenig, H.N. & Olive, F. (2004) The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Psychoneuroendocrinoly 29, 999-1003.
107. Koob, G.F. (2010) The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 1314, 3-14.
108. Koob, G.F. (2013) Addiction is a reward deficit and stress surfeit disorder. Front Psychiatry 4, 72. doi: 10.3389/fpsyt.2013.00072.
109. Koob, G.F. (2014) Neurocircuitry of alcohol addiction: synthesis from animal models. Handb Clin Neurol 125, 33-54.
110. Koob, G. & Kreek, M.J. (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164, 1149-1159.
111. Koob, G.F. & Le Moal, M. (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24, 97-129.
112. Koob, G.F. & Le Moal, M. (2008) Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 363, 3113-3123.
113. Koob, G.F. & Zorrilla, E.P. (2010) Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr Opin Investig Drugs 11, 63-71.
114. Koob, G.F. & Zorrilla, E.P. (2012) Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view. Neuropsychopharmacology 37, 308-309.
115. Koob, G.F., Buck, C.L., Cohen, A., Edwards, S., Park, P.E., Schlosburg, J.E., Schmeichel, B., Vendruscolo, L.F., Wade, C.L., Whitfield, T.W., Jr & George, O. (2014) Addiction as a stress surfeit disorder. Neuropharmacology, 76, 370-382.
116. Kormos, V. & Gaszner, B. (2013) Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides 47, 401-419.
117. Korosi, A., Veening, J.G., Kozicz, T., Henckens, M., Dederen, J., Groenink, L., van der Gugten, J., Olivier, B. & Roubos, E.W. (2006) Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Res 1072, 46-54.
118. Korosi, A., Kozicz, T., Richter, J., Veening, J.G., Olivier, B. & Roubos, E.W. (2007) Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. J Comp Neurol 502, 973-989.
119. Kozicz, T., Bittencourt, J.C., May, P.J., Reiner, A., Gamlin, P.D., Palkovits, M., Horn, A.K., Toledo, C.A. & Ryabinin, A.E. (2011) The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J Comp Neurol 519, 1413-1434.
120. Kozicz, T., Yanaihara, H. & Arimura, A. (1998) Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 391, 1-10.
121. Kühne, C., Puk, O., Graw, J., Hrabe de Angelis, M., Schutz, G., Wurst, W. & Deussing, J.M. (2012) Visualizing corticotropin-releasing hormone receptor type 1 expression and neuronal connectivities in the mouse using a novel multifunctional allele. J Comp Neurol 520, 3150-3180.
122. Läck, A.K., Floyd, D.W. & McCool, B.A. (2005) Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. Alcohol 36, 83-90.
123. Le, A.D., Harding, S., Juzytsch, W., Watchus, J., Shalev, U. & Shaham, Y. (2000) The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 150, 317-324.
124. Le, A.D., Harding, S., Juzytsch, W., Fletcher, P.J. & Shaham, Y. (2002) The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci 22, 7844-7849.
125. Le, A.D., Funk, D., Coen, K., Li, Z. & Shaham, Y. (2013) Role of corticotropin-releasing factor in the median raphe nucleus in yohimbine-induced reinstatement of alcohol seeking in rats. Addict Biol 18, 448-451.
126. Lee, S. & Rivier, C. (1997) An initial, three-day-long treatment with alcohol induces a long-lasting phenomenon of selective tolerance in the activity of the rat hypothalamic-pituitary-adrenal axis. J Neurosci 17, 8856-8866.
127. Lee, S., Schmidt, D., Tilders, F., Cole, M., Smith, A. & Rivier, C. (2000) Prolonged exposure to intermittent alcohol vapors blunts hypothalamic responsiveness to immune and non-immune signals. Alcohol Clin Exp Res 24, 110-122.
128. Lee, S., Schmidt, D., Tilders, F., Cole, M., Smith, A. & Rivier, C. (2001a) Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity. Alcohol Clin Exp Res 25, 98-105.
129. Lee, S., Smith, G.W., Vale, W., Lee, K.F. & Rivier, C. (2001b) Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression. Alcohol Clin Exp Res 25, 427-433.
130. Lee, S., Selvage, D., Hansen, K. & Rivier, C. (2004) Site of action of acute alcohol administration in stimulating the rat hypothalamic-pituitary-adrenal axis: comparison between the effect of systemic and intracerebroventricular injection of this drug on pituitary and hypothalamic responses. Endocrinology 145, 4470-4479.
131. Leggio, L., Cardone, S., Ferrulli, A., Kenna, G.A., Diana, M., Swift, R.M. & Addolorato, G. (2010) Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence. Curr Pharm Des 16, 2159-3018.
132. Lemos, J.C., Wanat, M.J., Smith, J.S., Reyes, B.A., Hollon, N.G., Van Bockstaele, E.J., Chavkin, C. & Phillips, P.E. (2012) Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature 490, 402-406.
133. Lewis, K., Li, C., Perrin, M.H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T.M., Gulyas, J., Fischer, W., Bilezikjian, L., Rivier, J., Sawchenko, P.E. & Vale, W.W. (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98, 7570-7575.
134. Leyton, M. & Vezina, P. (2014) Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model. Trends Pharmacol Sci 35, 268-276.
135. Li, C., Vaughan, J., Sawchenko, P.E. & Vale, W.W. (2002) Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22, 991-1001.
136. Lijffijt, M., Hu, K. & Swann, A.C. (2014) Stress modulates illness-course of substance use disorders: a translational review. Front Psychiatry 5, 83. doi: 10.3389/fpsyt.2014.00083.
137. Liu, X. & Weiss, F. (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22, 7856-7861.
138. Lodge, D.J. & Lawrence, A.J. (2003) The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats. Neuroscience 117, 243-247.
139. Logrip, M.L., Rivier, C., Lau, C., Im, S., Vaughan, J. & Lee, S. (2013) Adolescent alcohol exposure alters the rat adult hypothalamic-pituitary-adrenal axis responsiveness in a sex-specific manner. Neuroscience 235, 174-186.
140. Lowery, E.G. & Thiele, T.E. (2010) Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol Disord Drug Targets 9, 77-86.
141. Lowery, E.G., Sparrow, A.M., Breese, G.R., Knapp, D.J. & Thiele, T.E. (2008) The CRF-1 receptor antagonist, CP-154, 526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcohol Clin Exp Res 32, 240-248.
142. Lowery, E.G., Spanos, M., Navarro, M., Lyons, A.M., Hodge, C.W. & Thiele, T.E. (2010) CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology 35, 1241-1252.
143. Lowery-Gionta, E.G., Navarro, M., Li, C., Pleil, K.E., Rinker, J.A., Cox, B.R., Sprow, G.M., Kash, T.L. & Thiele, T.E. (2012) Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J Neurosci 32, 3405-3413.
144. Lu, Y.L. & Richardson, H.N. (2014) Alcohol, stress hormones, and the prefrontal cortex: a proposed pathway to the dark side of addiction. Neuroscience 277, 139-151.
145. Lukkes, J.L., Staub, D.R., Dietrich, A., Truitt, W., Neufeld-Cohen, A., Chen, A., Johnson, P.L., Shekhar, A. & Lowry, C.A. (2011) Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase. Neuroscience 183, 47-63.
146. Maisel, N.C., Blodgett, J.C., Wilbourne, P.L., Humphreys, K. & Finney, J.W. (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108, 275-293.
147. Manuel, R., Metz, J.R., Flik, G., Vale, W.W. & Huising, M.O. (2014) Corticotropin-releasing factor-binding protein (CRF-BP) inhibits CRF- and urotensin-I-mediated activation of CRF receptor-1 and -2 in common carp. Gen Comp Endocrinol 202, 69-75.
148. Marchant, N.J., Kaganovsky, K., Shaham, Y. & Booert, J.M. (2014) Role of corticostriatal circuits in context-induced reinstatement of drug seeking. Brain Res. doi: 10.1016/j.brainres.2014.09.004 [Epub ahead of print].
149. Marinelli, P.W., Funk, D., Juzytsch, W., Harding, S., Rice, K.C., Shaham, Y. & Le, A.D. (2007) The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl) 195, 345-355.
150. Marinelli, P.W., Funk, D., Juzytsch, W. & Le, A.D. (2010) Opioid receptors in the basolateral amygdala but not dorsal hippocampus mediate context-induced alcohol seeking. Behav Brain Res 211, 58-63.
151. Martin-Fardon, R., Zorrilla, E.P., Ciccocioppo, R. & Weiss, F. (2010) Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 1314, 145-161.
152. McReynolds, J.R., Pena, D.F., Blacktop, J.M. & Mantsch, J.R. (2014) Neurobiological mechanisms underlying relapse to cocaine use: contributions of CRF and noradrenergic systems and regulation by glucocorticoids. Stress 17, 22-38.
153. Meloni, E.G., Reedy, C.L., Cohen, B.M. & Carlezon, W.A. Jr. (2008) Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior. Biol Psychiatry 63, 832-839.
154. Méndez, M. & Morales-Mulia, M. (2008) Role of mu and delta opioid receptors in alcohol drinking behaviour. Curr Drug Abuse Rev 1, 239-252.
155. Merchenthaler, I., Vigh, S., Petrusz, P. & Schally, A.V. (1982) Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 165, 385-396.
156. Merchenthaler, I., Vigh, S., Schally, A.V., Stumpf, W.E. & Arimura, A. (1984) Immunocytochemical localization of corticotropin-releasing factor (CRF)-like immunoreactivity in the thalamus of the rat. Brain Res 323, 119-122.
157. Molander, A., Vengeliene, V., Heilig, M., Wurst, W., Deussing, J.M. & Spanagel, R. (2012) Brain-specific inactivation of the Crhr1 gene inhibits post-dependent and stress-induced alcohol intake, but does not affect relapse-like drinking. Neuropsychopharmacology 37, 1047-1056.
158. Morin, S.M., Ling, N., Liu, X.J., Kahl, S.D. & Gehlert, D.R. (1999) Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 92, 281-291.
159. Müller, M.B., Zimmermann, S., Sillaber, I., Hagemeyer, T.P., Deussing, J.M., Timpl, P., Kormann, M.S., Droste, S.K., Kuhn, R., Reul, J.M., Holsboer, F. & Wurst, W. (2003) Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 6, 1100-1107.
160. Myers, B., McKlveen, J.M. & Herman, J.P. (2014) Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front Neuroendocrinol 35, 180-196.
161. Nader, J., Chauvet, C., Rawas, R.E., Favot, L., Jaber, M., Thiriet, N. & Solinas, M. (2012) Loss of environmental enrichment increases vulnerability to cocaine addiction. Neuropsychopharmacology 37, 1579-1587.
162. Nie, Z., Schweitzer, P., Roberts, A.J., Madamba, S.G., Moore, S.D. & Siggins, G.R. (2004) Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 303, 1512-1514.
163. O'Callaghan, M.J., Croft, A.P., Jacquot, C. & Little, H.J. (2005) The hypothalamopituitary-adrenal axis and alcohol preference. Brain Res Bull 68, 171-178.
164. Ogilvie, K.M., Lee, S. & Rivier, C. (1998) Divergence in the expression of molecular markers of neuronal activation in the parvocellular paraventricular nucleus of the hypothalamus evoked by alcohol administration via different routes. J Neurosci 18, 4344-4352.
165. Oliva, J.M. & Manzanares, J. (2007) Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats. Neuropsychopharmacology 32, 1358-1369.
166. Olive, M.F., Mehmert, K.K., Messing, R.O. & Hodge, C.W. (2000) Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKC epsilon-deficient mice. Eur J Neurosci 12, 4131-4140.
167. Olive, M.F., Mehmert, K.K., Koenig, H.N., Camarini, R., Kim, J.A., Nannini, M.A., Ou, C.J. & Hodge, C.W. (2003) A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice. Psychopharmacology (Berl) 165, 181-187.
168. O'Malley, S.S., Garbutt, J.C., Gastfriend, D.R., Dong, Q. & Kranzler, H.R. (2007) Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. J Clin Psychopharmacol 27, 507-512.
169. Overstreet, D.H., Knapp, D.J. & Breese, G.R. (2004) Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol Biochem Behav 77, 405-413.
170. Overstreet, D.H., Knapp, D.J. & Breese, G.R. (2005) Pharmacological modulation of repeated ethanol withdrawal-induced anxiety-like behavior differs in alcohol-preferring P and Sprague-Dawley rats. Pharmacol Biochem Behav 81, 122-130.
171. Overstreet, D.H., Knapp, D.J. & Breese, G.R. (2007) Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats. Alcohol Clin Exp Res 31, 1473-1481.
172. Palchaudhuri, M.R., Hauger, R.L., Wille, S., Fuchs, E. & Dautzenberg, F.M. (1999) Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J Neuroendocrinol 11, 419-428.
173. Palmer, A.A., Sharpe, A.L., Burkhart-Kasch, S., McKinnon, C.S., Coste, S.C., Stenzel-Poore, M.P. & Phillips, T.J. (2004) Corticotropin-releasing factor overexpression decreases ethanol drinking and increases sensitivity to the sedative effects of ethanol. Psychopharmacology (Berl) 176, 386-397.
174. Pastor, R., McKinnon, C.S., Scibelli, A.C., Burkhart-Kasch, S., Reed, C., Ryabinin, A.E., Coste, S.C., Stenzel-Poore, M.P. & Phillips, T.J. (2008) Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism. Proc Natl Acad Sci U S A 105, 9070-9075.
175. Pastor, R., Reed, C., Burkhart-Kasch, S., Li, N., Sharpe, A.L., Coste, S.C., Stenzel-Poore, M.P. & Phillips, T.J. (2011) Ethanol concentration-dependent effects and the role of stress on ethanol drinking in corticotropin-releasing factor type 1 and double type 1 and 2 receptor knockout mice. Psychopharmacology (Berl) 218, 169-177.
176. Pastor, R., Reed, C., Meyer, P.J., McKinnon, C., Ryabinin, A.E. & Phillips, T.J. (2012) Role of corticotropin-releasing factor and corticosterone in behavioral sensitization to ethanol. J Pharmacol Exp Ther 341, 455-463.
177. Phillips, T.J., Roberts, A.J. & Lessov, C.N. (1997) Behavioral sensitization to ethanol: genetics and the effects of stress. Pharmcol Biochem Behav 57, 487-493.
178. Picetti, R., Schlussman, S.D., Zhou, Y., Ray, B., Ducat, E., Yuferov, V. & Kreek, M.J. (2013) Addictions and stress: clues for cocaine pharmacotherapies. Curr Pharm Des 19, 7065-7080.
179. Pitts, M.W., Todorovic, C., Blank, T. & Takahashi, L.K. (2009) The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory. J Neurosci 29, 7379-7388.
180. Potter, E., Behan, D.P., Linton, E.A., Lowry, P.J., Sawchenko, P.E. & Vale, W.W. (1992) The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci U S A 89, 4192-4196.
181. Przybycien-Szymanska, M.M., Rao, Y.S. & Pak, T.R. (2010) Binge-pattern alcohol exposure during puberty induces sexually dimorphic changes in genes regulating the HPA axis. Am J Physiol Endocrinol Metab 298, E320-E328.
182. Przybycien-Szymanska, M.M., Mott, N.N. & Pak, T.R. (2011) Alcohol dysregulates corticotropin-releasing-hormone (CRH) promoter activity by interfering with the negative glucocorticoid response element (nGRE). PLoS One 6, e26647. doi: 10.1371/journal.pone.0026647.
183. Radley, J.J. (2012) Toward a limbic cortical inhibitory network: implications for hypothalamic-pituitary-adrenal responses following chronic stress. Front Behav Neurosci 6, 7. doi: 10.3389/fnbeh.2012.00007.
184. Rasmussen, D.D., Boldt, B.M., Bryant, C.A., Mitton, D.R., Larsen, S.A. & Wilkinson, C.W. (2000) Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin Exp Res 24, 1836-1849.
185. Rassnick, S., Heinrichs, S.C., Britton, K.T. & Koob, G.F. (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605, 25-32.
186. Ravenelle, R., Byrnes, E.M., Byrnes, J.J., McInnis, C., Park, J.H. & Donaldson, S.T. (2013) Environmental enrichment effects on the neurobehavioral profile of selective outbred trait anxiety rats. Behav Brain Res 252, 49-57.
187. Refojo, D., Schweizer, M., Kuehne, C., Ehrenberg, S., Thoeringer, C., Vogl, A.M., Dedic, N., Schumacher, M., von Wolff, G., Avrabos, C., Touma, C., Engblom, D., Schutz, G., Nave, K.A., Eder, M., Wotjak, C.T., Sillaber, I., Holsboer, F., Wurst, W. & Deussing, J.M. (2011) Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 333, 1903-1907.
188. Reul, J.M.H.M. & Holsboer, F. (2002) On the role of corticotropin-releasing hormone receptors in anxiety and depression. Dialogues Clin Neurosci 4, 31-46.
189. Reyes, T.M., Lewis, K., Perrin, M.H., Kunitake, K.S., Vaughan, J., Arias, C.A., Hogenesch, J.B., Gulyas, J., Rivier, J., Vale, W.W. & Sawchenko, P.E. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 98, 2843-2848.
190. Reyes, B.A.S., Valentino, R.J. & Bockstaele, Van (2008) Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 149, 122-130.
191. Richardson, H.N., Lee, S.Y., O'Dell, L.E., Koob, G.F. & Rivier, C.L. (2008a) Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci 28, 1641-1653.
192. Richardson, H.N., Zhao, Y., Fekete, E.M., Funk, C.K., Wirsching, P., Janda, K.D., Zorrilla, E.P. & Koob, G.F. (2008b) MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharm Biochem Behav 88, 497-510.
193. Richter, R.M., Zorrilla, E.P., Basso, A.M., Koob, G.F. & Weiss, F. (2000) Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: a microdialysis and behavioral study. Alcohol Clin Exp Res 24, 1765-1772.
194. Rivier, C. (1996) Alcohol stimulates ACTH secretion in the rat: mechanisms of action and interactions with other stimuli. Alcohol Clin Exp Res 20, 240-254.
195. Rivier, C. (2014) Role of hypothalamic corticotropin-releasing factor in mediating alcohol-induced activation of the rat hypothalamic-pituitary-adrenal axis. Front Neuroendocrinol 35, 221-233.
196. Rivier, C. & Vale, W. (1983a) Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113, 939-942.
197. Rivier, C. & Vale, W. (1983b) Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305, 325-327.
198. Rivier, C., Rivier, J. & Vale, W. (1982) Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science 218, 377-379.
199. Rivier, C., Bruhn, T. & Vale, W. (1984) Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther 229, 127-131.
200. Roberto, M., Cruz, M.T., Gilpin, N.W., Sabino, V., Schweitzer, P., Bajo, M., Cottone, P., Madamba, S.G., Stouffer, D.G., Zorrilla, E.P., Koob, G.F., Siggins, G.R. & Parsons, L.H. (2010) Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol Psychiatry 67, 831-839.
201. Roberto, M., Gilpin, N.W. & Siggins, G.R. (2012) The central amygdala and alcohol: role of gamma-aminobutyric acid, glutamate, and neuropeptides. Cold Spring Harb Perspect Med 2, a012195. doi: 10.1101/cshperspect.a012195.
202. Roberts, A.J., Lessov, C.N. & Phillips, T.J. (1995) Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization. J Pharmacol Exp Ther 275, 790-797.
203. Robinson, T.E. & Berridge, K.C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18, 247-291.
204. Robinson, T.E. & Berridge, K.C. (2008) Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363, 3137-3146.
205. Roltsch, E.A., Baynes, B.B., Mayeux, J.P., Whitaker, A.M., Baiamonte, B.A. & Gilpin, N.W. (2014) Predator odor stress alters corticotropin-releasing factor-1 receptor (CRF1R)-dependent behaviors in rats. Neuropharmacology 79, 83-89.
206. Ryabinin, A.E. & Weitemier, A.Z. (2006) The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption. Brain Res Rev 52, 368-380.
207. Ryabinin, A.E., Tsivkovskaia, N.O. & Ryabinin, S.A. (2005) Urocortin 1-containing neurons in the human Edinger-Westphal nucleus. Neuroscience 134, 1317-1323.
208. Ryabinin, A.E., Yoneyama, N., Tanchuck, M.A., Mark, G.P. & Finn, D.A. (2008) Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption. Neuroscience 151, 780-790.
209. Ryabinin, A.E., Tsoory, M.M., Kozicz, T., Thiele, T.E., Neufeld-Cohen, A., Chen, A., Lowery-Gionta, E.G., Giardino, W.J. & Kaur, S. (2012) Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol 46, 349-357.
210. Sabino, V., Cottone, P., Koob, G.F., Steardo, L., Lee, M.J., Rice, K.C. & Zorrilla, E.P. (2006) Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 189, 175-186.
211. Sabino, V., Kwak, J., Rice, K.C. & Cottone, P. (2013) Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking. Alcohol Clin Exp Res 37, 635-643.
212. Sahuque, L.L., Kullberg, E.F., McGeehan, A.J., Kinder, J.R., Hicks, M.P., Blanton, M.G., Janak, P.H. & Olive, M.F. (2006) Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) 186, 122-132.
213. Salamone, J.D. & Correa, M. (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76, 470-485.
214. Sanchis-Segura, C. & Spanagel, R. (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11, 2-38.
215. Sarnyai, Z., Shaham, Y. & Heinrichs, S.C. (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53, 209-243.
216. Sawchenko, P.E., Swanson, L.W. & Vale, W.W. (1984) Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat. J Neurosci 4, 1118-1129.
217. Schultz, W. (2013) Updating dopamine reward signals. Curr Opin Neurobiol 23, 229-238.
218. Seasholtz, A.F., Valverde, R.A. & Denver, R.J. (2002) Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J Endocrinol 175, 89-97.
219. Segat, H.J., Kronbauer, M., Roversi, K., Schuster, A.J., Vey, L.T., Roversi, K., Pase, C.S., Antoniazzi, C.T. & Burger, M.E. (2014) Exercise modifies amphetamine relapse: behavioral and oxidative markers in rats. Behav Brain Res 262, 94-100.
220. Shalev, U., Erb, S. & Shaham, Y. (2010) Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 1314, 15-28.
221. Sharpe, A.L. & Phillips, T.J. (2009) Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice. Behav Pharmacol 20, 346-351.
222. Sharpe, A.L., Coste, S.C., Burkhart-Kasch, S., Li, N., Stenzel-Poore, M.P. & Phillips, T.J. (2005) Mice deficient in corticotropin-releasing factor receptor type 2 exhibit normal ethanol-associated behaviors. Alcohol Clin Exp Res 29, 1601-1609.
223. Shepard, J.D., Schulkin, J. & Myers, D.A. (2006) Chronically elevated corticosterone in the amygdala increases corticotropin releasing factor mRNA in the dorsolateral bed nucleus of stria terminalis following duress. Behav Brain Res 174, 193-196.
224. Silberman, Y. & Winder, D.G. (2013) Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward. Front Psychiatry 4, 42. doi: 10.3389/fpsyt.2013.00042.
225. Silberman, Y., Bajo, M., Chappell, A.M., Christian, D.T., Cruz, M., Diaz, M.R., Kash, T., Lack, A.K., Messing, R.O., Siggins, G.R., Winder, D., Roberto, M., McCool, B.A. & Weiner, J.L. (2009) Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions. Alcohol 43, 509-519.
226. Silberman, Y., Matthews, R.T. & Winder, D.G. (2013) A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis. J Neurosci 33, 950-960.
227. Sillaber, I., Rammes, G., Zimmermann, S., Mahal, B., Zieglgansberger, W., Wurst, W., Holsboer, F. & Spanagel, R. (2002) Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 296, 931-933.
228. Silva, S.M., Santos-Marques, M.J. & Madeira, M.D. (2009) Sexually dimorphic response of the hypothalamo-pituitary-adrenal axis to chronic alcohol consumption and withdrawal. Brain Res 1303, 61-73.
229. Simms, J.A., Nielsen, C.K., Li, R. & Bartlett, S.E. (2014) Intermittent access ethanol consumption dysregulates CRF function in the hypothalamus and is attenuated by the CRF-R1 antagonist, CP-376395. Addict Biol 19, 606-611.
230. Sinclair, D., Purves-Tyson, T.D., Allen, K.M. & Weickert, C.S. (2014) Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain. Psychopharmacology (Berl) 231, 1581-1599.
231. Sinha, R. (2008) Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141, 105-130.
232. Soliman, A., O'Driscoll, G.A., Pruessner, J., Holahan, A.L., Boileau, I., Gagnon, D. & Dagher, A. (2008) Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology 33, 2033-2041.
233. Solinas, M., Chauvet, C., Thiriet, N., El Rawas, R. & Jaber, M. (2008) Reversal of cocaine addiction by environmental enrichment. Proc Natl Acad Sci U S A 105, 17145-17150.
234. Sommer, W.H. & Saavedra, J.M. (2008) Targeting brain angiotensin and corticotrophin-releasing hormone systems interaction for the treatment of mood and alcohol use disorders. J Mol Med (Berl) 86, 723-728.
235. Sommer, W.H., Rimondini, R., Hansson, A.C., Hipskind, P.A., Gehlert, D.R., Barr, C.S. & Heilig, M.A. (2008) Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry 63, 139-145.
236. Spanagel, R., Noori, H.R. & Heilig, M. (2014) Stress and alcohol interactions: animal studies and clinical significance. Trends Neurosci 37, 219-227.
237. Sparta, D.R., Sparrow, A.M., Lowery, E.G., Fee, J.R., Knapp, D.J. & Thiele, T.E. (2008) Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 32, 259-265.
238. Sparta, D.R., Ferraro, F.M. III, Fee, J.R., Knapp, D.J., Breese, G.R. & Thiele, T.E. (2009) The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. Alcohol Clin Exp Res 33, 31-42.
239. Sparta, D.R., Hopf, F.W., Gibb, S.L., Cho, S.L., Stuber, G.D., Messing, R.O., Ron, D. & Bonci, A. (2013) Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area. Alcohol Clin Exp Res 37, 1680-1687.
240. Spiess, J., Rivier, J., Rivier, C. & Vale, W. (1981) Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A 78, 6517-6521.
241. Sprow, G.M. & Thiele, T.E. (2012) The neurobiology of binge-like ethanol drinking: evidence from rodent models. Physiol Behav 106, 325-331.
242. Steckler, T. & Holsboer, F. (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46, 1480-1508.
243. Stengel, A. & Tache, Y. (2014) CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front Neurosci 8, 52. doi: 10.3389/fnins.2014.00052.
244. Stephens, M.A. & Wand, G. (2012) Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res 34, 468-483.
245. Stinus, L., Cador, M., Zorrilla, E.P. & Koob, G.F. (2005) Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 30, 90-98.
246. Swanson, L.W., Sawchenko, P.E., Rivier, J. & Vale, W.W. (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36, 165-186.
247. Tanaka, Y., Makino, S., Noguchi, T., Tamura, K., Kaneda, T. & Hashimoto, K. (2003) Effect of stress and adrenalectomy on urocortin II mRNA expression in the hypothalamic paraventricular nucleus of the rat. Neuroendocrinology 78, 1-11.
248. Thiele, T.E. (2012) Commentary: studies on binge-like ethanol drinking may help to identify the neurobiological mechanisms underlying the transition to dependence. Alcohol Clin Exp Res 36, 193-196.
249. Thorberg, F.A. & Lyvers, M. (2006) Negative mood regulation (NMR) expectancies, mood, and affect intensity among clients in substance disorder treatment facilities. Addict Behav 31, 811-820.
250. Thorsell, A., Slawecki, C.J. & Ehlers, C.L. (2005) Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure. Behav Brain Res 161, 133-140.
251. Tran, L. & Greenwood-Van Meerveld, B. (2012) Altered expression of glucocorticoid receptor and corticotropin-releasing factor in the central amygdala in response to elevated corticosterone. Behav Brain Res 234, 380-385.
252. Treutlein, J., Kissling, C., Frank, J., Wiemann, S., Dong, L., Depner, M., Saam, C., Lascorz, J., Soyka, M., Preuss, U.W., Rujescu, D., Skowronek, M.H., Rietschel, M., Spanagel, R., Heinz, A., Laucht, M., Mann, K. & Schumann, G. (2006) Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11, 594-602.
253. Turek, V.F., Tsivkovskaia, N.O., Hyytia, P., Harding, S., Le, A.D. & Ryabinin, A.E. (2005) Urocortin 1 expression in five pairs of rat lines selectively bred for differences in alcohol drinking. Psychopharmacology (Berl) 181, 511-517.
254. Uhart, M. & Wand, G.S. (2009) Stress, alcohol and drug interaction: an update of human research. Addict Biol 14, 43-64.
255. Ungless, M.A., Singh, V., Crowder, T.L., Yaka, R., Ron, D. & Bonci, A. (2003) Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39, 401-407.
256. Valdez, G.R. & Koob, G.F. (2004) Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav 79, 671-689.
257. Valdez, G.R., Roberts, A.J., Chan, K., Davis, H., Brennan, M., Zorrilla, E.P. & Koob, G.F. (2002) Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26, 1494-1501.
258. Valdez, G.R., Zorrilla, E.P., Roberts, A.J. & Koob, G.F. (2003) Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 29, 55-60.
259. Valdez, G.R., Sabino, V. & Koob, G.F. (2004) Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcohol Clin Exp Res 28, 865-872.
260. Vale, W., Spiess, J., Rivier, C. & Rivier, J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397.
261. Vale, W., Vaughan, J., Smith, M., Yamamoto, G., Rivier, J. & Rivier, C. (1983) Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology 113, 1121-1131.
262. Van Pett, K., Viau, V., Bittencourt, J.C., Chan, R.K., Li, H.Y., Arias, C., Prins, G.S., Perrin, M., Vale, W. & Sawchenko, P.E. (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428, 191-212.
263. Van Waes, V., Darnaudery, M., Marrocco, J., Gruber, S.H., Talavera, E., Mairesse, J., Van Camp, G., Casolla, B., Nicoletti, F., Mathe, A.A., Maccari, S. & Morley-Fletcher, S. (2011) Impact of early life stress on alcohol consumption and on the short- and long-term responses to alcohol in adolescent female rats. Behav Brain Res 221, 43-49.
264. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M.H., Lewis, K., Sutton, S., Chan, R., Turnbull, A.V., Lovejoy, D., Rivier, C. et al. (1995) Urocortin, a mammalian stress-induced increases in EtOH intake to be absent in CRF1 KO mice. Nature 378, 287-292.
265. Vendruscolo, L.F. & Roberts, A.J. (2014) Operant alcohol self-administration in dependent rats: focus on the vapor model. Alcohol 48, 277-286.
266. Vendruscolo, L.F., Barbier, E., Schlosburg, J.E., Misra, K.K., Whitfield, T.W. Jr., Logrip, M.L., Rivier, C., Repunte-Canonigo, V., Zorrilla, E.P., Sanna, P.P., Heilig, M. & Koob, G.F. (2012) Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci 32, 7563-7571.
267. Walker, D.L. & Davis, M. (2008) Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct Funct 213, 29-42.
268. Walker, D.L., Miles, L.A. & Davis, M. (2009) Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry 33, 1291-1308.
269. Wand, G.S. & Dobs, A.S. (1991) Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab 72, 1290-1295.
270. Weiss, F., Ciccocioppo, R., Parsons, L.H., Katner, S., Liu, X., Zorrilla, E.P., Valdez, G.R., Ben-Shahar, O., Angeletti, S. & Richter, R.R. (2001) Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci 937, 1-26.
271. Weitemier, A.Z. & Ryabinin, A.E. (2006) Urocortin 1 in the dorsal raphe regulates food and fluid consumption, but not ethanol preference in C57BL/6J mice. Neuroscience 137, 1439-1445.
272. Wills, T.A., Knapp, D.J., Overstreet, D.H. & Breese, G.R. (2009) Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats. Alcohol Clin Exp Res 33, 455-463.
273. Wills, T.A., Knapp, D.J., Overstreet, D.H. & Breese, G.R. (2010) Interactions of stress and CRF in ethanol-withdrawal induced anxiety in adolescent and adult rats. Alcohol Clin Exp Res 34, 1603-1612.
274. Wise, R.A. (2008) Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14, 169-183.
275. Wise, R.A. & Koob, G.F. (2014) The development and maintenance of drug addiction. Neuropsychopharmacology 39, 254-262.
276. Wise, R.A. & Morales, M. (2010) A ventral tegmental CRF-glutamate-dopamine interaction in addiction. Brain Res 1314, 38-43.
277. Wong, C.C. & Schumann, G. (2012) Integration of the circadian and stress systems: influence of neuropeptides and implications for alcohol consumption. J Neural Transm 119, 1111-1120.
278. Xu, J., Sun, J., Xue, Z. & Li, X. (2014) An enriched environment reduces the stress level and locomotor activity induced by acute morphine treatment and by saline after chronic morphine treatment in mice. Neuroreport 25, 701-709.
279. Yang, X., Wang, S., Rice, K.C., Munro, C.A. & Wand, G.S. (2008) Restraint stress and ethanol consumption in two mouse strains. Alcohol Clin Exp Res 32, 840-852.
280. Yong, W., Spence, J.P., Eskay, R., Fitz, S.D., Damadzic, R., Lai, D., Foroud, T., Carr, L.G., Shekhar, A., Chester, J.A., Heilig, M. & Liang, T. (2014) Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring rats. Alcohol Clin Exp Res 38, 1275-1283.
281. Zhao, Z., Jin, X., Wu, Y., Yang, X., Xu, Y., Jiang, J.Z., Kim, S.C., Lee, B.H., Yang, C.H. & Zhao, R. (2013) Amygdaloid corticotropin-releasing factor is involved in the anxiolytic effect of acupuncture during ethanol withdrawal in rats. J Acupunct Meridian Stud 6, 234-240.
282. Zhou, Y., Colombo, G., Gessa, G.L. & Kreek, M.J. (2013) Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats. Neurosci Lett 554, 110-114.
283. Zorrilla, E.P. & Koob, G.F. (2004) The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs 13, 799-828.
284. Zorrilla, E.P. & Koob, G.F. (2010) Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov Today 15, 371-383.
285. Zorrilla, E.P., Valdez, G.R., Nozulak, J., Koob, G.F. & Markou, A. (2002) Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res 952, 188-199.
286. Zorrilla, E.P., Heilig, M., de Wit, H. & Shaham, Y. (2013) Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend 128, 175-186.
287. Zorrilla, E.P., Logrip, M.L. & Koob, G.F. (2014) Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol 35, 234-244.